4.01 (-%)
As of Nov 21, 2024
Source:
Xenetic Biosciences, Inc is a biopharmaceutical company focused onadvancing innovative immune-oncology technologies addressing hard to treat cancers. Our DNase platform is designed to improve outcomesof existing treatments, including immunotherapies, by targeting NETs.
| Country | United States |
| Headquarters | framingham, massachusetts |
| Phone Number | 781-778-7720 |
| Industry | manufacturing |
| CEO | Jeffrey F. Eisenberg |
| Website | www.xeneticbio.com |